发明名称 Improved lipid formulation for the delivery of nucleic acids
摘要 IMPROVED LIPID FORMULATION FOR THE DELIVERY OF NUCLEIC ACIDS Abstract: The invention features an improved lipid formulation comprising a cationic lipid of formula (A), a neutral lipid, a sterol and a PEG or PEG-modified lipid, where R 1 and R 2 are independently alkyl, alkenyl or alkynyl, each can be optionally substituted, and R 3 and R 4 are independently lower alkyl or R 3 and R 4 can be taken together to form an optionally subsituted heterocyclic ring. In one embodiment, R 1 and R 2 are independently selected from oleoyl, pamitoyl, steroyl, linoleyl and R 3 and R 4 are methyl. Also disclosed are targeting lipids, and specific lipid formulations comprising such targeting lipids. N-R4 (A) o 0 1j> R2
申请公布号 AU2016228298(A1) 申请公布日期 2016.10.06
申请号 AU20160228298 申请日期 2016.09.16
申请人 Arbutus Biopharma Corporation 发明人 Akinc, Akin;Querbes, William;Wong, Frances;Dorkin, Joseph Robert;Qin, Xiaojun;Cantley, William;Borodovsky, Anna;De, Soma;Manoharan, Muthiah;Jayaraman, Muthusamy;Rajeev, Kallanthottathil G.
分类号 A61K9/127;A61K48/00 主分类号 A61K9/127
代理机构 代理人
主权项
地址